Catalyst Oncology is a niche oncology clinical research organization (CRO) devoting time, energy, and capital to supporting biotechs in bringing next-generation hematologic oncology (heme/onc) therapies to cancer patients. Clinical trials in hematologic malignancies are complex, more so than in solid tumors and thus require a higher level of expertise in your CRO partner. Bringing effective heme/onc therapies to proof-of-concept and then to market as fast as possible is our mission because every second counts for patients living with blood cancer and their families.
Active portfolio in a range of hematologic oncology trials
Seasoned oncology experts
With an average of 9+ years of oncology experience for key roles (PM, CTL, DM, Clinical Science), our oncology specialty guarantees you a seasoned team across all functions.
Additional differentiators
Active next-generation oncology experience
Working largely in early- to mid-phase development across a range of both solid and hematologic indications, we understand the nuances of complex study designs, novel endpoints, and cutting-edge technologies.